Quidel Corporation Company Profile (NASDAQ:QDEL)

About Quidel Corporation (NASDAQ:QDEL)

Quidel Corporation logoQuidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Health Care Supplies
  • Symbol: NASDAQ:QDEL
  • CUSIP: 74838J10
  • Web: www.quidel.com
Capitalization:
  • Market Cap: $1.09 billion
  • Outstanding Shares: 33,440,000
Average Prices:
  • 50 Day Moving Avg: $32.13
  • 200 Day Moving Avg: $25.45
  • 52 Week Range: $18.25 - $38.92
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 85.82
  • P/E Growth: 5.80
Sales & Book Value:
  • Annual Revenue: $214.11 million
  • Price / Sales: 5.09
  • Book Value: $6.36 per share
  • Price / Book: 5.13
Profitability:
  • EBIDTA: $39.38 million
  • Net Margins: -0.03%
  • Return on Equity: -0.03%
  • Return on Assets: -0.02%
Debt:
  • Debt-to-Equity Ratio: 0.71%
  • Current Ratio: 7.19%
  • Quick Ratio: 6.46%
Misc:
  • Average Volume: 325,761 shs.
  • Beta: 1.28
  • Short Ratio: 7
 

Frequently Asked Questions for Quidel Corporation (NASDAQ:QDEL)

What is Quidel Corporation's stock symbol?

Quidel Corporation trades on the NASDAQ under the ticker symbol "QDEL."

How were Quidel Corporation's earnings last quarter?

Quidel Corporation (NASDAQ:QDEL) announced its quarterly earnings data on Wednesday, July, 26th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by $0.18. The business earned $38.30 million during the quarter, compared to the consensus estimate of $41.91 million. Quidel Corporation had a negative net margin of 0.03% and a negative return on equity of 0.03%. The firm's revenue for the quarter was down 2.0% compared to the same quarter last year. During the same quarter last year, the company earned ($0.11) EPS. View Quidel Corporation's Earnings History.

When will Quidel Corporation make its next earnings announcement?

Quidel Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Quidel Corporation.

Where is Quidel Corporation's stock going? Where will Quidel Corporation's stock price be in 2017?

6 analysts have issued 12-month price objectives for Quidel Corporation's stock. Their forecasts range from $22.00 to $41.00. On average, they anticipate Quidel Corporation's share price to reach $31.75 in the next year. View Analyst Ratings for Quidel Corporation.

Who are some of Quidel Corporation's key competitors?

Who are Quidel Corporation's key executives?

Quidel Corporation's management team includes the folowing people:

  • Kenneth F. Buechler Ph.D., Chairman of the Board
  • Douglas C. Bryant, President, Chief Executive Officer, Director
  • Randall J. Steward, Chief Financial Officer
  • Robert Joseph Bujarski J.D., Senior Vice President - Business Development, General Counsel and Corporate Secretary
  • Michael D. Abney Jr., Senior Vice President - Distribution
  • Werner Kroll Ph.D, Senior Vice President,R&D
  • Edward Keith Russell, Senior Vice President - Global Commercial Operations
  • John D. Tamerius Ph.D., Senior Vice President - Strategic and External Affairs
  • Charles P. Slacik CPA, Director
  • Thomas D. Brown, Independent Director

Who owns Quidel Corporation stock?

Quidel Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (6.56%), Macquarie Group Ltd. (3.87%), New York State Common Retirement Fund (2.67%), Dimensional Fund Advisors LP (2.53%), Fred Alger Management Inc. (2.01%) and Gamco Investors INC. ET AL (1.89%). Company insiders that own Quidel Corporation stock include Douglas C Bryant, John Tamerius, Michael Donald Jr Abney, Randall J Steward and Robert Joseph Bujarski. View Institutional Ownership Trends for Quidel Corporation.

Who sold Quidel Corporation stock? Who is selling Quidel Corporation stock?

Quidel Corporation's stock was sold by a variety of institutional investors in the last quarter, including Investment Management of Virginia LLC, ETRADE Capital Management LLC, Trexquant Investment LP, Parametric Portfolio Associates LLC, Pitcairn Co., California State Teachers Retirement System, Alliancebernstein L.P. and Dimensional Fund Advisors LP. Company insiders that have sold Quidel Corporation stock in the last year include Douglas C Bryant, John Tamerius, Michael Donald Jr Abney, Randall J Steward and Robert Joseph Bujarski. View Insider Buying and Selling for Quidel Corporation.

Who bought Quidel Corporation stock? Who is buying Quidel Corporation stock?

Quidel Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Chicago Equity Partners LLC, Marshall Wace North America L.P., Renaissance Technologies LLC, Janus Henderson Group PLC, Acadian Asset Management LLC, Spark Investment Management LLC, Macquarie Group Ltd. and Arrowstreet Capital Limited Partnership. View Insider Buying and Selling for Quidel Corporation.

How do I buy Quidel Corporation stock?

Shares of Quidel Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quidel Corporation's stock price today?

One share of Quidel Corporation stock can currently be purchased for approximately $32.61.


MarketBeat Community Rating for Quidel Corporation (NASDAQ QDEL)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  168 (Vote Underperform)
Total Votes:  309
MarketBeat's community ratings are surveys of what our community members think about Quidel Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Quidel Corporation (NASDAQ:QDEL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $31.75 (2.64% downside)

Analysts' Ratings History for Quidel Corporation (NASDAQ:QDEL)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/27/2017Raymond James Financial, Inc.Boost Price TargetOutperform$36.00 -> $41.00HighView Rating Details
7/27/2017Barclays PLCBoost Price TargetOverweight$36.00 -> $39.00HighView Rating Details
7/18/2017William BlairUpgradeMarket Perform -> OutperformHighView Rating Details
7/18/2017Canaccord GenuityUpgradeHold -> BuyHighView Rating Details
2/17/2017CL KingInitiated CoverageNeutralN/AView Rating Details
12/16/2016Piper Jaffray CompaniesDowngradeOverweight -> Neutral$22.00N/AView Rating Details
2/18/2016Craig HallumLower Price TargetHold$18.00 -> $16.00N/AView Rating Details
(Data available from 8/20/2015 forward)

Earnings

Earnings History for Quidel Corporation (NASDAQ:QDEL)
Earnings by Quarter for Quidel Corporation (NASDAQ:QDEL)
Earnings History by Quarter for Quidel Corporation (NASDAQ QDEL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017N/AView Earnings Details
7/26/2017Q2 2017($0.17)($0.35)$41.91 million$38.30 millionViewN/AView Earnings Details
4/24/2017Q1 2017$0.15$0.45$61.85 million$73.70 millionViewN/AView Earnings Details
2/8/2017Q416$0.02$0.17$58.42 million$52.80 millionViewListenView Earnings Details
10/26/2016Q316($0.02)$0.10$50.88 million$49.30 millionViewListenView Earnings Details
7/27/2016Q216($0.25)($0.11)$37.98 million$39.10 millionViewListenView Earnings Details
4/27/2016Q116($0.07)$0.02$49.21 million$50.30 millionViewListenView Earnings Details
2/17/2016Q415$0.05$0.10$54.01 million$52.40 millionViewListenView Earnings Details
10/28/2015Q315($0.14)$0.05$43.48 million$46.80 millionViewListenView Earnings Details
7/22/2015Q215($0.25)($0.14)$34.17 million$34.87 millionViewListenView Earnings Details
4/23/2015Q115$0.12$0.30$61.22 million$61.30 millionViewListenView Earnings Details
2/11/2015Q414$0.10$0.37$60.61 million$63.60 millionViewListenView Earnings Details
10/21/2014Q314($0.12)($0.01)$37.80 million$40.90 millionViewListenView Earnings Details
7/22/2014Q214($0.16)($0.10)$31.90 million$31.50 millionViewListenView Earnings Details
4/23/2014Q114$0.30$0.08$63.26 million$46.70 millionViewListenView Earnings Details
2/11/2014Q413$0.09$0.20$48.67 million$50.00 millionViewListenView Earnings Details
10/23/2013Q313($0.07)($0.02)$37.32 million$33.50 millionViewListenView Earnings Details
7/30/2013Q2 2013($0.11)($0.06)$33.24 million$29.71 millionViewListenView Earnings Details
4/23/2013Q1 2013$0.46$0.49$62.63 million$61.99 millionViewN/AView Earnings Details
2/12/2013Q4 2012$0.29$0.26$53.30 million$53.93 millionViewListenView Earnings Details
10/23/2012($0.03)$0.08ViewN/AView Earnings Details
7/25/2012($0.08)$0.01ViewN/AView Earnings Details
2/29/2012$0.06$0.15ViewN/AView Earnings Details
10/25/2011($0.06)($0.03)ViewN/AView Earnings Details
8/2/2011($0.07)($0.04)ViewN/AView Earnings Details
4/28/2011$0.33$0.35ViewN/AView Earnings Details
2/24/2011($0.01)$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Quidel Corporation (NASDAQ:QDEL)
Current Year EPS Consensus Estimate: $0.28 EPS
Next Year EPS Consensus Estimate: $0.38 EPS

Dividends

Dividend History for Quidel Corporation (NASDAQ:QDEL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Quidel Corporation (NASDAQ:QDEL)
Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 89.66%
Insider Trades by Quarter for Quidel Corporation (NASDAQ:QDEL)
Institutional Ownership by Quarter for Quidel Corporation (NASDAQ:QDEL)
Insider Trades by Quarter for Quidel Corporation (NASDAQ:QDEL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/31/2017Douglas C BryantCEOSell36,000$33.83$1,217,880.00View SEC Filing  
7/28/2017Michael Donald Jr. AbneySVPSell1,173$33.83$39,682.59View SEC Filing  
7/28/2017Randall J StewardCFOSell94,215$34.09$3,211,789.35View SEC Filing  
6/30/2017Douglas C BryantCEOSell36,000$27.30$982,800.00View SEC Filing  
5/31/2017Douglas C BryantCEOSell36,000$24.98$899,280.00View SEC Filing  
5/30/2017Douglas C BryantCEOSell12,000$25.10$301,200.00View SEC Filing  
5/26/2017Douglas C BryantCEOSell12,000$24.90$298,800.00View SEC Filing  
5/2/2017Robert Joseph BujarskiSVPSell43,225$24.27$1,049,070.75View SEC Filing  
5/1/2017Robert Joseph BujarskiSVPSell33,225$24.20$804,045.00View SEC Filing  
4/28/2017Douglas C BryantCEOSell36,000$24.16$869,760.00View SEC Filing  
3/31/2017Douglas C BryantCEOSell37,080$22.50$834,300.00View SEC Filing  
2/28/2017Douglas C. BryantCEOSell106,920$21.39$2,287,018.80View SEC Filing  
12/1/2016Robert Joseph BujarskiSVPSell60,000$22.84$1,370,400.00View SEC Filing  
11/30/2016Douglas C BryantCEOSell72,000$22.89$1,648,080.00View SEC Filing  
11/29/2016Douglas C BryantCEOSell24,000$22.84$548,160.00View SEC Filing  
11/28/2016Douglas C BryantCEOSell24,000$23.02$552,480.00View SEC Filing  
11/25/2016John TameriusSVPSell8,878$23.50$208,633.00View SEC Filing  
9/30/2016Douglas C BryantCEOSell69,168$21.76$1,505,095.68View SEC Filing  
8/30/2016Douglas C BryantCEOSell2,832$22.00$62,304.00View SEC Filing  
8/9/2016Robert Joseph BujarskiSVPSell22,057$22.58$498,047.06View SEC Filing  
8/1/2016John TameriusSVPSell7,000$23.02$161,140.00View SEC Filing  
2/19/2016Douglas C. BryantCEOBuy3,700$13.91$51,467.00View SEC Filing  
12/2/2015John TameriusSVPSell21,109$21.95$463,342.55View SEC Filing  
10/30/2015Douglas C BryantCEOBuy20,000$19.76$395,200.00View SEC Filing  
10/3/2014John TameriusSVPSell5,000$28.00$140,000.00View SEC Filing  
9/18/2014John TameriusSVPSell10,000$26.50$265,000.00View SEC Filing  
7/24/2014Douglas C BryantCEOBuy20,000$24.12$482,400.00View SEC Filing  
7/23/2014John TameriusSVPSell15,000$24.50$367,500.00View SEC Filing  
6/24/2014John TameriusSVPSell5,000$23.06$115,300.00View SEC Filing  
2/26/2014John TameriusSVPSell47,246$27.69$1,308,241.74View SEC Filing  
2/13/2014Rodney DammeyerDirectorSell26,000$27.70$720,200.00View SEC Filing  
10/29/2013Mark PulidoDirectorSell12,750$25.31$322,702.50View SEC Filing  
5/29/2013Robert Joseph BujarskiSVPSell28,808$23.16$667,193.28View SEC Filing  
5/17/2013Robert Joseph BujarskiSVPSell27,479$23.12$635,314.48View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Quidel Corporation (NASDAQ:QDEL)
Latest Headlines for Quidel Corporation (NASDAQ:QDEL)
Source:
DateHeadline
finance.yahoo.com logoETFs with exposure to Quidel Corp. : August 15, 2017
finance.yahoo.com - August 16 at 7:03 AM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) Expected to Post Quarterly Sales of $50.69 Million
www.americanbankingnews.com - August 4 at 7:08 AM
americanbankingnews.com logoZacks: Analysts Anticipate Quidel Corporation (QDEL) Will Post Earnings of -$0.03 Per Share
www.americanbankingnews.com - August 3 at 12:32 AM
finance.yahoo.com logoQuidel Corp. :QDEL-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017
finance.yahoo.com - August 2 at 6:56 AM
americanbankingnews.com logoMichael Donald Jr. Abney Sells 1,173 Shares of Quidel Corporation (QDEL) Stock
www.americanbankingnews.com - August 1 at 10:14 PM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) CFO Randall J. Steward Sells 94,215 Shares
www.americanbankingnews.com - August 1 at 10:12 PM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) CEO Douglas C. Bryant Sells 36,000 Shares
www.americanbankingnews.com - August 1 at 10:47 AM
americanbankingnews.com logoQuidel Corporation (QDEL) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 1 at 9:23 AM
americanbankingnews.com logoQuidel Corporation (QDEL) Rating Lowered to C at TheStreet
www.americanbankingnews.com - July 30 at 8:33 PM
americanbankingnews.com logoQuidel Corporation (QDEL) Lowered to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - July 29 at 8:36 AM
americanbankingnews.com logoDextera Surgical (DXTR) versus Quidel Corporation (NASDAQ:QDEL) Critical Analysis
www.americanbankingnews.com - July 27 at 10:36 AM
finance.yahoo.com logoQuidel Reports Second Quarter 2017 Financial Results
finance.yahoo.com - July 27 at 6:42 AM
finance.yahoo.com logoEdited Transcript of QDEL earnings conference call or presentation 26-Jul-17 9:00pm GMT
finance.yahoo.com - July 27 at 6:42 AM
finance.yahoo.com logoQuidel reports 2Q loss
finance.yahoo.com - July 27 at 6:42 AM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) Releases Earnings Results, Misses Expectations By $0.03 EPS
www.americanbankingnews.com - July 26 at 9:15 PM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) Downgraded by Zacks Investment Research
www.americanbankingnews.com - July 23 at 12:00 AM
finance.yahoo.com logoCorporate News Blog - Quidel to Acquire Alere Triage(R) Assets
finance.yahoo.com - July 20 at 7:01 AM
rttnews.com logoQuidel Corp. (QDEL) Surged To A New High After Buying Assets From Alere
www.rttnews.com - July 19 at 6:08 AM
zacks.com logoQuidel (QDEL) Worth a Look: Stock Jumps 25.4% in Session
www.zacks.com - July 19 at 6:08 AM
seekingalpha.com logoQuidel (QDEL) Updates On Acquisition Of Alere's Triage (ALR) Assets - Slideshow
seekingalpha.com - July 19 at 6:08 AM
fool.com logoHere's Why Quidel Corporation Is Rising Today
www.fool.com - July 18 at 1:17 PM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) Lifted to Buy at Canaccord Genuity
www.americanbankingnews.com - July 18 at 10:40 AM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - July 18 at 9:11 AM
feeds.benzinga.com logoMid-Afternoon Market Update: Peregrine Pharma Drops After Q4 Results; Quidel Shares Jump
feeds.benzinga.com - July 17 at 3:48 PM
rttnews.com logoMarket Enthusiastic Ahead Of Earnings Season
www.rttnews.com - July 17 at 8:33 AM
seekingalpha.com logoQuidel announces definitive agreement to acquire Alere Triage Assets
seekingalpha.com - July 17 at 8:33 AM
finance.yahoo.com logoQuidel Announces Definitive Agreement to Acquire Alere Triage® Assets
finance.yahoo.com - July 17 at 8:33 AM
americanbankingnews.com logoBidaskClub Downgrades Quidel Corporation (NASDAQ:QDEL) to Buy
www.americanbankingnews.com - July 16 at 10:08 PM
finance.yahoo.com logoQuidel to Hold Second Quarter 2017 Financial Results Conference Call on July 26, 2017
finance.yahoo.com - July 15 at 7:50 AM
americanbankingnews.com logo Brokerages Anticipate Quidel Corporation (NASDAQ:QDEL) Will Post Quarterly Sales of $42.17 Million
www.americanbankingnews.com - July 13 at 10:00 AM
americanbankingnews.com logoZacks: Brokerages Expect Quidel Corporation (QDEL) to Announce -$0.17 Earnings Per Share
www.americanbankingnews.com - July 11 at 6:16 PM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) Upgraded by TheStreet to "B-"
www.americanbankingnews.com - July 11 at 11:54 AM
americanbankingnews.com logoQuidel Corporation (NASDAQ:QDEL) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 7 at 8:11 AM
americanbankingnews.com logoQuidel Corporation (QDEL) CEO Douglas C. Bryant Sells 36,000 Shares
www.americanbankingnews.com - June 30 at 10:30 PM
finance.yahoo.com logoQuidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Respiratory Syncytial Virus (RSV) Assay
finance.yahoo.com - June 29 at 6:24 AM
finance.yahoo.com logoQuidel’s Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards from Good Design Australia®’s 2017 Good Design Awards®
finance.yahoo.com - June 23 at 9:22 AM
americanbankingnews.com logo Brokerages Anticipate Quidel Corporation (QDEL) Will Post Quarterly Sales of $42.17 Million
www.americanbankingnews.com - June 17 at 8:46 AM
americanbankingnews.com logo-$0.17 EPS Expected for Quidel Corporation (QDEL) This Quarter
www.americanbankingnews.com - June 15 at 6:28 PM
americanbankingnews.com logoOxford Immunotec Global PLC (OXFD) & Quidel Corporation (QDEL) Head to Head Contrast
www.americanbankingnews.com - June 13 at 8:16 PM
americanbankingnews.com logoIDEXX Laboratories (IDXX) & Quidel Corporation (QDEL) Financial Comparison
www.americanbankingnews.com - June 13 at 4:49 PM
americanbankingnews.com logoQuidel Corporation (QDEL) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 12 at 8:48 AM
finance.yahoo.com logoQuidel Receives the CE Mark for Its Thyretain® TBI Reporter BioAssay
finance.yahoo.com - June 8 at 12:23 AM
americanbankingnews.com logoReviewing Trinity Biotech plc (TRIB) and Quidel (QDEL)
www.americanbankingnews.com - June 5 at 4:10 PM
americanbankingnews.com logoInsider Selling: Quidel Co. (QDEL) CEO Sells 12,000 Shares of Stock
www.americanbankingnews.com - May 31 at 10:28 PM
americanbankingnews.com logoQuidel Co. (QDEL) CEO Sells $899,280.00 in Stock
www.americanbankingnews.com - May 31 at 10:26 PM
finance.yahoo.com logoQuidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Immunoassay Analyzer for Use with Sofia Influenza A+B Assay
finance.yahoo.com - May 30 at 7:05 PM
seekingalpha.com logoFDA OKs Quidel's flu test for Sofia analyzer; shares up 2%
seekingalpha.com - May 30 at 4:17 PM
finance.yahoo.com logoQuidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay
finance.yahoo.com - May 25 at 5:47 AM
finance.yahoo.com logoETFs with exposure to Quidel Corp. : May 18, 2017
finance.yahoo.com - May 19 at 12:16 PM
americanbankingnews.com logoQuidel's (QDEL) "Hold" Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - May 19 at 10:52 AM

Social

Chart

Quidel Corporation (QDEL) Chart for Sunday, August, 20, 2017

This page was last updated on 8/20/2017 by MarketBeat.com Staff